Get in touch

Tiefenbacher New Market Launch: Buprenorphine Patches in South Africa

Tiefenbacher Group - A smiling older man with a gray beard sits while a woman stands behind him, hugging him. Text reads, "LAUNCH OF BUPRENORPHINE IN SOUTH AFRICA." The TIEFENBACHER PHARMACEUTICALS logo is at the top, highlighting expertise in generic medicines manufacturing.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in South Africa. We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. That’s why we are thrilled to share that we have successfully prepared the launch of the generic version […]

Exciting Days at DCAT in New York!

Tiefenbacher Group - A group of seven smiling people in business attire take a selfie on a busy city street. A banner reads, "Tiefenbacher sends greetings from the DCAT." The TIEFENBACHER GROUP logo highlights this family-owned pharmaceutical company.

Our team sends greetings and impressions from the Big Apple!As we approach the final stretch of DCAT Week 2025 in New York, we reflect on an incredibly successful event so far! The Tiefenbacher Group team has had the privilege of engaging in insightful conversations, strengthening partnerships, and showcasing our latest innovations to make pharmaceuticals more […]

Tiefenbacher Group, OnDosis and Star celebrate iF Design Award for OYSTA

Tiefenbacher Group - A digital display showcases Oysta, a patient management tool focused on patient-centric drug development, on a tablet and smartphone. The Tiefenbacher Group and IF Design Award logos highlight ONDOSIS & STAR's award-winning design for Oysta.

We are proud to announce that OYSTA has been honored with the prestigious iF Design Award for its excellence in digital innovation and user-centric design.This award is a testament to our shared vision and collaborative efforts of our partners—global life science company OnDosis AB and global technology consultancy Star—to redefine medication management for ADHD and […]

Lindus Health and Tiefenbacher Group Launching Clinical Trial

Tiefenbacher Group - A woman sits on a couch with a blanket over her shoulders, eyes closed, pinching the bridge of her nose in discomfort. Text reads: “Tiefenbacher Group & Lindus Health launching clinical trial on ME/CFS and patient-centric drug development.”.

Lindus Health and Tiefenbacher Group are launching a clinical trial to advance ME/CFS research and treatment. At Tiefenbacher Group, we are committed to driving innovation in healthcare and addressing unmet medical needs.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a serious and complex chronic condition affecting multiple body systems. Characterized by severe fatigue, post-exertional malaise (PEM), […]

Tiefenbacher Pharmaceuticals Launch: Varenicline in UK

Tiefenbacher Group - A woman in a blue knit hat and winter coat stands outdoors with eyes closed. Text reads, "Launch of Varenicline in the United Kingdom." The TIEFENBACHER Pharmaceuticals logo, a family-owned pharmaceutical company, appears at the top left.

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the United Kingdom We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of Varenicline in the UnitedKingdom! WHO has added Varenicline to the […]

Tiefenbacher Pharmaceuticals New Market Launch: Amifampridine

Tiefenbacher Group - An older couple dressed in winter gear stands smiling on a snowy mountain with trekking poles. The Tiefenbacher Pharmaceuticals logo highlights the launch of Amifampridine across Europe by this family-owned pharmaceutical company.

Tiefenbacher Pharmaceuticals Successfully Prepares the Launch of Amifampridine Across Europe At Tiefenbacher Pharmaceuticals, we are deeply committed to making high-quality, life-changing medications affordable and accessible to patients worldwide, regardless of, nationality, or income. That’s why we are excited to share that we have successfully prepared the launch of Amifampridine Tablets 10mg. This is the first generic […]

Tiefenbacher Group provides insights into practice

Tiefenbacher Group - A man speaks in front of a chalkboard and a projected slide listing discussion topics. The Tiefenbacher Group logo and the text "Tiefenbacher Group at Kiel & Düsseldorf University" highlight its role in generic medicines manufacturing.

Insights into Practice: Tiefenbacher Group at the University of Kiel and DusseldorfLast week, Tiefenbacher Group had the fantastic opportunity to get in touch with pharmacy students at the University of Kiel and the University of Düsseldorf, to provide them insights into practice. Together with our Managing Director Dr. Kristian Ruepp, Dr. Simon Bock from Market […]

Tiefenbacher Group and Pharmacists Without Borders

Tiefenbacher Group - Four volunteers in a warehouse sort and pack boxes of donated goods for families in Ukraine. Shelves and tables are filled with supplies, and the Tiefenbacher Group logo highlights their commitment to pharmaceutical healthcare solutions.

We are proud to share an update on our partnership with Pharmacists Without Borders (“Apotheker ohne Grenzen Deutschland e.V.”).At Tiefenbacher Group, we believe our culture of caring is essential to achieving our goal of significantly making a difference in the daily lives of people around the world. That’s why we are supporting the projects of […]

Tiefenbacher Group Celebrating World Pharmacists Day

Tiefenbacher Group - A smiling pharmacist in a white coat talks to a customer at the pharmacy counter. Shelves with medicine are in the background, highlighting pharmaceutical healthcare solutions. Text reads "World Pharmacists Day.

On this World Pharmacists Day, we at Tiefenbacher Group join the global community in celebrating the theme “Pharmacists: Meeting global health needs”.This day, organized by the International Pharmaceutical Federation (FIP), highlights the vital role pharmacists play in enhancing healthcare systems worldwide —something we deeply value, as many of our own team members are certified pharmacists. […]

Tiefenbacher Pharmaceuticals New Market Launch: Ezetimibe/Atorvastatin

Tiefenbacher Group - Smiling older man outdoors, wearing a blue vest and carrying a backpack. Text: "Launch of Ezetimibe / Atorvastatin in European Union." Family-owned pharmaceutical company focused on patient-centric drug development. TIEFENBACHER PHARMACEUTICALS logo at the top.

Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared […]

Tiefenbacher Pharmaceuticals First to Market Launch: Varenicline in Europe

Tiefenbacher Group - A young woman stands outdoors with her eyes closed and hands on her chest, appearing calm and content. Text reads: "Launch of Varenicline across European Union." Tiefenbacher Pharmaceuticals, a family-owned pharmaceutical company, logo is at the top.

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of the only available Varenicline containing product in Europe. WHO has […]

Tiefenbacher New Market Launch: Buprenorphine in Australia

Tiefenbacher Group - An older smiling couple embraces outdoors. The image features the logo "Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, and a banner reading "Launch of the analgesic buprenorphine in Australia.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled […]

Tiefenbacher New Market Launch: Bilastine as Oral Dispersible Tablet (ODT)

Tiefenbacher Group - A young girl with a flower crown sits in a field of wildflowers, holding a tissue to her nose. Text reads: "Launch of the antihistamine bilastine as oral dispersible tablet—a finished dosage form." TIEFENBACHER PHARMACEUTICALS logo appears above.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) medicine in GermanyAs the allergy season is in full swing, we at Tiefenbacher Group are thrilled to announce that we have successfully prepared the launch of our latest anti-allergy medicine, Bilastine Oral Dispersible Tablet (ODT) in Germany, which is now available […]

Tiefenbacher first-to-market launch: Rivaroxaban

Tiefenbacher Group - A smiling older couple embraces outdoors in a garden, looking happy and relaxed. The man wears a blue shirt; the woman, a light pink top. The "Tiefenbacher Pharmaceuticals" logo highlights their family-owned pharmaceutical company in the upper left corner.

Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of Rivaroxaban.   […]

Tiefenbacher New Market Launch: Rivaroxaban in Canada

Tiefenbacher Group - A smiling older woman with short gray hair joyfully gives a piggyback ride to a laughing older man outdoors, highlighting Tiefenbacher Pharmaceuticals' commitment to generic medicines manufacturing. The company logo is in the top left corner.

Tiefenbacher Pharmaceuticals successfully launches the anticoagulant Rivaroxaban on day one in CanadaWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled to share that […]

Tiefenbacher New Market Launch: generic launch Teriflunomide

Tiefenbacher Group - A smiling woman in a navy raincoat stands on a beach, holding her hood. The AET TIEFENBACHER PHARMACEUTICALS logo appears in the top left, reflecting their focus on patient-centric drug development. The background shows the sea and greenery.

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a day one launch of the generic version of the Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio). This complex generic launch explicitly follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals […]

State-of-the-art R&D facilities for powerful drug development

Tiefenbacher Group - A large group gathers outdoors under a colorful canopy for a groundbreaking ceremony as a priest leads rituals. Highlighting Tiefenbacher Group’s family-owned pharmaceutical company and patient-centric drug development, event details frame the image.

State-of-the-art R&D facilities for powerful drug development and manufacturing. New technology for generic, valued added, and innovative pharmaceuticalsWe, at Tiefenbacher Group, go beyond R&D and manufacturing of pharmaceuticals with a commitment to quality, safety, and reliability that is anchored in everything we do. We continuously expand in novel technologies and capabilities to improve quality and […]

SFDA approves Tiefenbacher facilities

Tiefenbacher Group - Aerial view of Riyadh city skyline at sunset with modern skyscrapers, including the Kingdom Centre, under a dramatic sky. "Tiefenbacher Group" logo is at the top left, representing pharmaceutical healthcare solutions.

Tiefenbacher: Own manufacturing and laboratory facilities successfully registered by the Saudi Food and Drug Authority (SFDA) for GCC regionThe SFDA approves Tiefenbacher facilities! We are happy to announce that our manufacturing and laboratory facilities for oral solids at AET Laboratories in Hyderabad (India) have been successfully registered by the Saudi Food and Drug Authority (SFDA). […]

Tiefenbacher Generic Launch: antihistamine Bilastine

Tiefenbacher Group - A smiling young man in a blue shirt lies on his back in green grass with his hands behind his head, reflecting the patient-centric drug development focus of Tiefenbacher Pharmaceuticals. The company’s logo appears in the top left corner.

Generic Launch: Tiefenbacher Pharmaceuticals successfully launches the antihistamine Bilastine for a market entry as over-the-counter (OTC) medicine in germanyGeneric drugs: As the allergy season is starting, we at Tiefenbacher Pharmaceuticals are thrilled to announce that we have successfully prepared the launch of the antihistamine Bilastine for a market entry as Over-the-counter (OTC) medicine in Germany. […]

Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)

Tiefenbacher Group - A smiling woman in a green top and backpack stands with arms outstretched before lush mountains and fields. The logo and text "Tiefenbacher Pharmaceuticals" highlights their pharmaceutical healthcare solutions in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are excited to share that we have successfully prepared the launch of the generic version of Apremilast […]

Tiefenbacher Pharmaceuticals New Market Launch: Abiraterone for prostate cancer

Tiefenbacher Group - An older man with gray hair smiles while sitting on a couch, wearing a light gray shirt. The logo and name "AET Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, is visible in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launces generic version of the prostate cancer medicines Abiraterone and the value-added product Abiraterone/PrednisoloneWe at Tiefenbacher Pharmaceuticals aim to improve peoples´ lives around the world by making medicines better affordable, better available, and better than before! That´s why we are excited to share that we have successfully prepared the […]

TIEFENBACHER GROUP opens new manufacturing site in Cyprus

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

TIEFENBACHER GROUP opens new manufacturing site in Cyprus for drug production of high-quality pharmaceuticals – we continuously expand in novel technologies and capabilities to improve quality and boost 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Did you know that TIEFENBACHER GROUP heavily invests in its in-house production capacities for high-quality pharmaceuticals? We continuously expand in novel technologies and capabilities to improve quality […]

Tiefenbacher Pharmaceuticals New Market Launch: Apixaban anticoagulant

Tiefenbacher Group - An older man with gray hair, wearing a yellow long-sleeve shirt and backpack, walks in a lush riverside landscape. In the corner, the logo and text read "AET TIEFENBACHER PHARMACEUTICALS," a family-owned pharmaceutical company.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the anticoagulant medicine Apixaban in CanadaWe at Tiefenbacher Pharmaceuticals are driven by enabling people around the world a better access to more affordable high-quality medicines. That´s why we are happy to share that we have successfully prepared the launch of the generic version of Apixaban for […]

Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin

Tiefenbacher Group - Two older women smiling and hugging outdoors, both appearing joyful. The logo and text “AET TIEFENBACHER PHARMACEUTICALS” is visible in the top left corner, highlighting patient-centric drug development.

NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines available and affordable to as many people as possible around the world. Therefore Tiefenbacher Group is happy to share that we have successfully prepared the launch of […]

Tiefenbacher Pharmaceuticals New Market Launch: Rivaroxaban

Tiefenbacher Group - A young man and an older man in patterned shirts and a hat smile together outdoors. The AET Tiefenbacher Pharmaceuticals logo appears in the top left corner, highlighting expertise in pharmaceutical healthcare solutions.

Global market launch: TIEFENBACHER PHARMACEUTICALS expands the launch of the anticoagulant medicine Rivaroxaban to Central America and further international marketsWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available for all patients around the world – irrespective of their origin or nationality. That´s why we are happy to share that we have successfully […]

Tiefenbacher Pharmaceuticals New Market Launch: Teriflunomide

Tiefenbacher Group - A smiling woman in a blue rain jacket takes a selfie outdoors by a rocky river, holding her hood with one hand. Trees and misty mountains are in the background. The Tiefenbacher Pharmaceuticals logo highlights patient-centric drug development.

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE MULTIPLE SCLEROSIS MEDICINE TERIFLUNOMIDE IN CANADAWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are happy to share that we have successfully prepared the launch of the generic version […]

TIEFENBACHER GROUP OPENS NEW SITE FOR HIGHLY POTENT DRUGS IN INDIA

Tiefenbacher Group - A collage showing groups of people smiling, a modern building with the AETI logo, and a hallway lined with scientific equipment highlights pharmaceutical healthcare solutions. The bottom right corner features the TIEFENBACHER GROUP logo.

TIEFENBACHER GROUP opens new site for highly potent drugs in India – we continuously expand in novel technologies and capabilities to improve quality and boost productivity of better healthcareTiefenbacher Group is excited to announce the ceremonious opening of our new highly potent drug laboratory in Hyderabad, India. The completion of the new building is the […]

Tiefenbacher Pharmaceuticals New Market Launch: Lacosamide

Tiefenbacher Group - A smiling man gives a piggyback ride to a woman by the sea, both looking happy. The TIEFENBACHER PHARMACEUTICALS logo appears in the top left corner, representing family-owned pharmaceutical company values. The background shows water, grass, and a cloudy sky.

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE EPILEPSY MEDICINE LACOSAMIDE IN AUSTRALIAWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their income level or nationality. That´s why we are happy to share that we have […]

TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus

Tiefenbacher Group - A collage showcases Tiefenbacher Group facilities, highlighting modern glass-fronted offices, industrial buildings, manufacturing equipment, and the Tiefenbacher Group logo, reflecting their commitment to patient-centric drug development and pharmaceutical healthcare solutions.

Driving efficiency is our key – TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus for powerful drug productionDid you know that TIEFENBACHER GROUP heavily invests in its own manufacturing facilities to secure an efficient and reliable supply of our high-quality pharmaceuticals for patients around the world? As fully integrated pharmaceutical company, we offer […]

Tiefenbacher Pharmaceuticals: Launch of first generic version of the antihistamine Bilastine

Tiefenbacher Group - A smiling woman with long hair stands in a field of yellow flowers under a clear sky. The Tiefenbacher Pharmaceuticals logo in the top left highlights their dedication to patient-centric drug development and innovative pharmaceutical healthcare solutions.

New market launch: TIEFENBACHER PHARMACEUTICALS successfully launches first generic version of the antihistamine BilastineWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable for all patients irrespective of their income level or nationality. That´s why we are excited to share that we have successfully launched the first generic version of Bilastine (20 […]

TIEFENBACHER PHARMACEUTICALS: Launch of generic version of Teriflunomide, Multiple Sclerosis (MS)

Tiefenbacher Group - A group of five older adults, three men and two women, stand close together outdoors, smiling and laughing under leafy trees on a sunny day, reflecting the joy that patient-centric drug development brings to thriving communities in a lush park setting.

TIEFENBACHER PHARMACEUTICALS announces global generic launch of Teriflunomide – making multiple sclerosis therapy more affordable and better available worldwideTiefenbacher Pharmaceuticals has successfully developed a global dossier for a generic version of Teriflunomide 7 mg and 14 mgfilm-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. Teriflunomide […]

AET Pharma US Inc., Part of Tiefenbacher, approval of Abbreviated New Drug Application (ANDA) for Posaconazole

Tiefenbacher Group - A large group of people, including men and women in formal and colorful traditional attire, stand on a grassy lawn with a modern glass building behind them, reflecting the unity of a family-owned pharmaceutical company dedicated to patient-centric drug development.

AET Pharma US Inc. announces successful approval of Abbreviated New Drug Application (ANDA) for PosaconazoleOn 1st February 2021, AET Pharma US Inc, part of TIEFENBACHER GROUP, received FDA approval of the Abbreviated New Drug Application (ANDA) for Posaconazole in 100 mg Delayed-Release Tablets. This is another milestone for TIEFENBACHER GROUP in further strengthening its product […]

TIEFENBACHER PHARMACEUTICALS: Launch of Rivaroxaban

Tiefenbacher Group - Blister packs of white pills and capsules are arranged on a white surface, overlaid with translucent blue hexagons and digital interface elements, reflecting patient-centric drug development by a family-owned pharmaceutical company.

TIEFENBACHER PHARMACEUTICALS announces global launch of Rivaroxaban – an anticoagulant medication (blood thinner)Tiefenbacher Pharmaceuticals, part of Tiefenbacher Group, is pleased to announce the availability of a registration dossier for the generic of Rivaroxaban 2.5 mg, 10 mg, 15 mg and 20 mg film-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower […]

International Brand Relaunch of Tiefenbacher Group

Tiefenbacher Group - A man in a dark suit and glasses sits on a chair by a large window overlooking modern office buildings and a waterfront. He is smiling, has short, light hair, and projects the professionalism of a family-owned pharmaceutical company.

Tiefenbacher Group: Improving people’s life by making pharmaceuticals more affordable, more available, and better than before”We are very excited to launch the new Tiefenbacher Group website. It represents the fundamental changes which we have started in the recent years. We are on the move to drive important efficiencies in our supply chain and become a […]

Get in touch